CD8A Antibody

Shipped with Ice Packs
In Stock

Description

Applications of CD8A Antibodies

CD8A antibodies are widely used in:

ApplicationKey DetailsClone Examples
Flow cytometryIdentifies CD8+ T-cell populations in blood, spleen, and thymus .HIT8a (human), 53-6.7 (mouse)
ImmunohistochemistryDetects CD8+ cells in frozen tissue sections .HIT8a, 53-6.7
T-cell activation/depletionBlocks ligand binding or isolates CD8+ subsets .53-6.7, SK1
Immuno-PET imagingMonitors tumor-infiltrating lymphocytes (e.g., 89Zr-DFO-REGN5054 in cancer) .REGN5054

Antibody-Induced T-Cell Activation

  • OKT8 (anti-human CD8α): Triggers effector functions (cytokine release, cytotoxicity) in CD8+ T cells by enhancing TCR/pMHCI binding .

  • CT-CD8a/b (anti-mouse): Activates murine CD8+ T cells, improving pMHCI tetramer staining .

Functional Heterogeneity

  • Only 1/7 tested anti-human CD8 antibodies (OKT8) activated T cells, highlighting clone-specific effects .

  • Preclinical studies with REGN5054 demonstrated safe CD8+ T-cell tracking in cancer models without disrupting immune function .

Blocking vs. Non-Blocking Antibodies

  • 53-6.7 (mouse): Inhibits MHC class I antigen presentation and IL-2 responses .

  • HIT8a (human): No reported activation, making it ideal for diagnostic staining .

Clinical Relevance

CD8A antibodies are advancing cancer immunotherapy:

  • REGN5054: A humanized antibody used in immuno-PET to visualize CD8+ tumor-infiltrating lymphocytes pre-/post-therapy .

  • Combination therapies: CD8+ T-cell activation by bispecific antibodies (e.g., REGN1979) enhances tumor clearance .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
CD8AT-cell surface glycoprotein CD8 alpha chain antibody; CD antigen CD8a antibody
Target Names
Uniprot No.

Target Background

Function
CD8A is an integral membrane glycoprotein that plays a critical role in the immune response. It performs multiple functions in defending against both external and internal threats. In T-cells, CD8A primarily serves as a coreceptor for MHC class I molecule:peptide complexes. Class I peptides present antigens derived from cytosolic proteins, while class II peptides present antigens derived from extracellular proteins. CD8A interacts simultaneously with the T-cell receptor (TCR) and MHC class I proteins presented by antigen-presenting cells (APCs). This interaction recruits the Src kinase LCK to the TCR-CD3 complex, initiating various intracellular signaling pathways by phosphorylating key substrates. Ultimately, this leads to lymphokine production, cell motility, adhesion, and activation of cytotoxic T-lymphocytes (CTLs). This mechanism enables CTLs to recognize and eliminate infected cells and tumor cells. In NK-cells, CD8A homodimers at the cell surface promote survival, allowing conjugation and lysis of multiple target cells. CD8A homodimer molecules also contribute to the survival and differentiation of activated lymphocytes into memory CD8 T-cells.
Database Links

KEGG: bta:281060

STRING: 9913.ENSBTAP00000028175

UniGene: Bt.50

Subcellular Location
Cell membrane; Single-pass type I membrane protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.